How are we using synthetic biology?
Improving therapeutics for Type 1 diabetes
Gaby Markle ’26 was diagnosed with Type 1 diabetes when she was 4 years old. Working with Cornell CALS biological and environmental engineering professor Minglin Ma, Gaby is researching potential treatments using synthetic biology.
Discovering new genes
Cameron Xu ’26 is using biometry and statistics to help Cornell CALS animal science professor Vimal Selvaraj identify new genes. Together, they’re exploring how steroid hormones regulate the body’s processes, uncovering new knowledge that could advance cancer research and solve other human health challenges.
Study synthetic biology
This research field combines disciplines in ways that allow us to find new answers to old questions. Explore our programs:
-
Undergraduate major & minor
-
Undergraduate major
-
Undergraduate major
-
Undergraduate major & minor
-
Undergraduate major
-
Undergraduate major & minor
-
Undergraduate major
-
Department
-
Undergraduate major & minor
News
News
News
To conduct low-cost and scalable synthetic biological experiments, Cornell researchers have created a new version of a microbe to compete economically with E. coli – a bacteria used to synthesize proteins.
News
Researchers created a new technique to treat Type 1 diabetes: implanting a device inside a pocket under the skin that can secrete insulin while avoiding the immunosuppression that typically stymies management of the disease.
Explore our expertise
- (607) 255-2923
- Alireza [at] cornell.edu
- (607) 255-9183
- sda23 [at] cornell.edu
- bmb35 [at] cornell.edu
- haf54 [at] cornell.edu
- lhg42 [at] cornell.edu
- (607) 255-9185
- snugen [at] cornell.edu